RECRUITING

Alio WEAR Study: Long-term Wear of the Alio Platform

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The WEAR study is long-term interventional study designed to evaluate patient and clinician use of the Alio platform, per its FDA cleared indications.

Official Title

Alio WEAR Study: Long-term Wear of the Alio Platform

Quick Facts

Study Start:2023-10-09

Study Completion:2024-04-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06056739

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* At least 18 years of age. * Receiving hemodialysis via an AVF or AVG in an arm location at the time of study start. * Able to wear the SmartPatch effectively at the specified location on the arm. * Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures. * Willing and able to wear the SmartPatch as instructed and comply with all interviews, surveys and questionnaires, and schedule of evaluations.	* Skin near the proximity of the AV access that is chronically swollen, infected, inflamed, open wounds, lesions, or has skin eruptions. * Participation in any other clinical trials involving investigational or marketed products that in the opinion of the investigator could affect the quality of the data. * Other conditions that in the opinion of the Principal Investigator may increase risk to the subject and/or compromise the quality of the clinical trial.

Inclusion Criteria

Exclusion Criteria

* At least 18 years of age.
* Receiving hemodialysis via an AVF or AVG in an arm location at the time of study start.
* Able to wear the SmartPatch effectively at the specified location on the arm.
* Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.
* Willing and able to wear the SmartPatch as instructed and comply with all interviews, surveys and questionnaires, and schedule of evaluations.

* Skin near the proximity of the AV access that is chronically swollen, infected, inflamed, open wounds, lesions, or has skin eruptions.
* Participation in any other clinical trials involving investigational or marketed products that in the opinion of the investigator could affect the quality of the data.
* Other conditions that in the opinion of the Principal Investigator may increase risk to the subject and/or compromise the quality of the clinical trial.

Contacts and Locations

Study Contact

Amy Steig

CONTACT

4158348031

amy@alio.ai

Tala Harake

CONTACT

9499235884

tala@alio.ai

Principal Investigator

David Whittaker, MD

STUDY_DIRECTOR

Alio

Study Locations (Sites)

Site 1

Huntley, Illinois, 60142

United States

Collaborators and Investigators

Sponsor: Alio, Inc.

David Whittaker, MD, STUDY_DIRECTOR, Alio

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-09

Study Completion Date2024-04-01

Study Record Updates

Study Start Date2023-10-09

Study Completion Date2024-04-01

Terms related to this study

Additional Relevant MeSH Terms

End Stage Kidney Disease